Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 223

1.

CD8 T cell recognition of endogenously expressed epstein-barr virus nuclear antigen 1.

Lee SP, Brooks JM, Al-Jarrah H, Thomas WA, Haigh TA, Taylor GS, Humme S, Schepers A, Hammerschmidt W, Yates JL, Rickinson AB, Blake NW.

J Exp Med. 2004 May 17;199(10):1409-20.

2.

Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells.

Mautner J, Pich D, Nimmerjahn F, Milosevic S, Adhikary D, Christoph H, Witter K, Bornkamm GW, Hammerschmidt W, Behrends U.

Eur J Immunol. 2004 Sep;34(9):2500-9.

3.

Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1.

Tellam J, Connolly G, Green KJ, Miles JJ, Moss DJ, Burrows SR, Khanna R.

J Exp Med. 2004 May 17;199(10):1421-31.

5.

Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1.

Blake NW, Moghaddam A, Rao P, Kaur A, Glickman R, Cho YG, Marchini A, Haigh T, Johnson RP, Rickinson AB, Wang F.

J Virol. 1999 Sep;73(9):7381-9.

6.

Epstein-Barr virus nuclear antigen 1-specific CD4+ T cells directly kill Epstein-Barr virus-carrying natural killer and T cells.

Demachi-Okamura A, Ito Y, Akatsuka Y, Tsujimura K, Morishima Y, Takahashi T, Kuzushima K.

Cancer Sci. 2008 Aug;99(8):1633-42. doi: 10.1111/j.1349-7006.2008.00852.x.

7.
8.

Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing.

Blake N, Lee S, Redchenko I, Thomas W, Steven N, Leese A, Steigerwald-Mullen P, Kurilla MG, Frappier L, Rickinson A.

Immunity. 1997 Dec;7(6):791-802.

9.

Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1.

Yin Y, Manoury B, Fåhraeus R.

Science. 2003 Sep 5;301(5638):1371-4.

10.

Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1.

Münz C, Bickham KL, Subklewe M, Tsang ML, Chahroudi A, Kurilla MG, Zhang D, O'Donnell M, Steinman RM.

J Exp Med. 2000 May 15;191(10):1649-60.

11.

Full-length EBNA1 mRNA-transduced dendritic cells stimulate cytotoxic T lymphocytes recognizing a novel HLA-Cw*0303- and -Cw*0304-restricted epitope on EBNA1-expressing cells.

Ito Y, Demachi-Okamura A, Ohta R, Akatsuka Y, Nishida K, Tsujimura K, Morishima Y, Takahashi T, Kuzushima K.

J Gen Virol. 2007 Mar;88(Pt 3):770-80.

PMID:
17325349
13.

Discerning regulation of cis- and trans-presentation of CD8+ T-cell epitopes by EBV-encoded oncogene LMP-1 through self-aggregation.

Smith C, Wakisaka N, Crough T, Peet J, Yoshizaki T, Beagley L, Khanna R.

Blood. 2009 Jun 11;113(24):6148-52. doi: 10.1182/blood-2009-02-203687. Epub 2009 Apr 16.

15.

The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from the EBV nuclear antigen EBNA1.

Blake N, Haigh T, Shaka'a G, Croom-Carter D, Rickinson A.

J Immunol. 2000 Dec 15;165(12):7078-87.

16.

Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders.

Jones K, Nourse JP, Morrison L, Nguyen-Van D, Moss DJ, Burrows SR, Gandhi MK.

Blood. 2010 Sep 30;116(13):2245-52. doi: 10.1182/blood-2010-03-274076. Epub 2010 Jun 18.

17.

A repetitive sequence of Epstein-Barr virus nuclear antigen 6 comprises overlapping T cell epitopes which induce HLA-DR-restricted CD4(+) T lymphocytes.

Rajnavölgyi E, Nagy N, Thuresson B, Dosztányi Z, Simon A, Simon I, Karr RW, Ernberg I, Klein E, Falk KI.

Int Immunol. 2000 Mar;12(3):281-93.

18.

Targeting of EBNA1 for rapid intracellular degradation overrides the inhibitory effects of the Gly-Ala repeat domain and restores CD8+ T cell recognition.

Tellam J, Sherritt M, Thomson S, Tellam R, Moss DJ, Burrows SR, Wiertz E, Khanna R.

J Biol Chem. 2001 Sep 7;276(36):33353-60. Epub 2001 Jul 2.

19.

Identification of a naturally processed HLA-DR-restricted T-helper epitope in Epstein-Barr virus nuclear antigen type 1.

Krüger S, Schroers R, Rooney CM, Gahn B, Chen SY.

J Immunother. 2003 May-Jun;26(3):212-21.

PMID:
12806275
20.

Avoiding proteasomal processing: the case of EBNA1.

Dantuma NP, Sharipo A, Masucci MG.

Curr Top Microbiol Immunol. 2002;269:23-36. Review.

PMID:
12224511
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk